News
Our CEO Breaks Down the 2026 CMS Policy and What It Means for the MarketOur CEO Breaks Down the 2026 CMS Policy and What It Means for the Market
Our CEO, Rob Odell, explains the 2026 CMS payment reform for skin substitutes, its impact on providers, patients, and innovation across wound care.
Our CEO Breaks Down the 2026 IPAWS Market Review: What’s Ahead for Advanced Wound Care
Our CEO, Rob Odell, breaks down the 2026 IPAWS market outlook, covering reimbursement changes, mobile wound care, innovation trends, and industry adaptation.